Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Britschgi

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Journal of Parkinson'S Disease|February 26, 2026
Quantitative measures of total and phosphorylated alpha-synuclein in skin tissue as potential biomarkers for synucleinopathiesBram L van der Gaag, Janna van Wetering, Martino L Morella, et al.
Scientific Reports|December 22, 2018
Cerebral Corpora amylacea are dense membranous labyrinths containing structurally preserved cell organellesPaula P Navarro, Christel Genoud, Daniel Castaño-Díez, et al.
The Journal of Experimental Medicine|March 17, 2017
Microglial complement receptor 3 regulates brain Aβ levels through secreted proteolytic activityEva Czirr, Nicholas A Castello, Kira I Mosher, et al.
Molecular Neurodegeneration|June 3, 2021
Parkinson mice show functional and molecular changes in the gut long before motoric disease onsetManuela Gries, Anne Christmann, Steven Schulte, et al.
Free Neuropathology|June 7, 2023
Specific immune modulation of experimental colitis drives enteric alpha-synuclein accumulation and triggers age-related Parkinson-like brain pathologyStefan Grathwohl, Emmanuel Quansah, Nazia Maroof, et al.
Nature|September 3, 2011
The ageing systemic milieu negatively regulates neurogenesis and cognitive functionSaul A Villeda, Jian Luo, Kira I Mosher, et al.
Acta Neuropathologica|June 11, 2021
The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson's disease brain as revealed by multicolor STED microscopyTim E Moors, Christina A Maat, Daniel Niedieker, et al.
Frontiers in Neurology|October 18, 2021
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline DataGennaro Pagano, Frank G Boess, Kirsten I Taylor, et al.
Nature Medicine|October 16, 2007
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteinsSandip Ray, Markus Britschgi, Charles Herbert, et al.
Nature Metabolism|July 23, 2020
Eosinophils regulate adipose tissue inflammation and sustain physical and immunological fitness in old ageDaniel Brigger, Carsten Riether, Robin van Brummelen, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of Parkinson'S Disease|February 26, 2026
Quantitative measures of total and phosphorylated alpha-synuclein in skin tissue as potential biomarkers for synucleinopathiesBram L van der Gaag, Janna van Wetering, Martino L Morella, et al.
Scientific Reports|December 22, 2018
Cerebral Corpora amylacea are dense membranous labyrinths containing structurally preserved cell organellesPaula P Navarro, Christel Genoud, Daniel Castaño-Díez, et al.
The Journal of Experimental Medicine|March 17, 2017
Microglial complement receptor 3 regulates brain Aβ levels through secreted proteolytic activityEva Czirr, Nicholas A Castello, Kira I Mosher, et al.
Molecular Neurodegeneration|June 3, 2021
Parkinson mice show functional and molecular changes in the gut long before motoric disease onsetManuela Gries, Anne Christmann, Steven Schulte, et al.
Free Neuropathology|June 7, 2023
Specific immune modulation of experimental colitis drives enteric alpha-synuclein accumulation and triggers age-related Parkinson-like brain pathologyStefan Grathwohl, Emmanuel Quansah, Nazia Maroof, et al.
Nature|September 3, 2011
The ageing systemic milieu negatively regulates neurogenesis and cognitive functionSaul A Villeda, Jian Luo, Kira I Mosher, et al.
Acta Neuropathologica|June 11, 2021
The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson's disease brain as revealed by multicolor STED microscopyTim E Moors, Christina A Maat, Daniel Niedieker, et al.
Frontiers in Neurology|October 18, 2021
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline DataGennaro Pagano, Frank G Boess, Kirsten I Taylor, et al.
Nature Medicine|October 16, 2007
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteinsSandip Ray, Markus Britschgi, Charles Herbert, et al.
Nature Metabolism|July 23, 2020
Eosinophils regulate adipose tissue inflammation and sustain physical and immunological fitness in old ageDaniel Brigger, Carsten Riether, Robin van Brummelen, et al.
Pageof 5